Top

Netherlands Heart Journal

Published in:

Open Access 01-01-2016 | Editorial Comment

To implant or not to implant?

That is the unsolved question concerning heart failure patients with non-LBBB

Authors: M. Zarse, B. Lemke

Published in: Netherlands Heart Journal | Issue 1/2016

Excerpt

With their article published in this issue of the Journal, Stipdonk and colleagues touch on a subject bearing significant clinical implications [1]. …

Stipdonk AMW van, Rad MM, Luermans JGLM, Crijns HJ, Prinzen FW, Vernooy K. Identifying delayed left ventricular lateral wall activation in patients with non-specific intraventricular conduction delay using coronary venous electroanatomical mapping. Neth Heart J. 2016;24. doi:10.1007/s12471-015-0777-3.

Bristow MR, Saxon LA, Boehmer J; the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.PubMedCrossRef

Cleland J, Daubert JC, Erdmann E; the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.PubMedCrossRef

Ruschitzka F, Abraham WT, Singh JP. Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex. N Engl J Med. 2013;369:1395–405.PubMedCrossRef

Brignole M, Auricchio A, Esquivias GB. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2013;34:2281–329.PubMedCrossRef

Zareba W, Klein H, Cygankiewicz I; the MADIT-CRT investigators, et al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial – Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011;123:1061–72.PubMedCrossRef

Title: To implant or not to implant?
That is the unsolved question concerning heart failure patients with non-LBBB
Authors: M. Zarse
B. Lemke
Publication date: 01-01-2016
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 1/2016
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-015-0778-2

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

To implant or not to implant?

That is the unsolved question concerning heart failure patients with non-LBBB

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2016

The influence of right ventricular stimulation on acute response to cardiac resynchronisation therapy

Identifying delayed left ventricular lateral wall activation in patients with non-specific intraventricular conduction delay using coronary venous electroanatomical mapping

Upgrading and replacement in CRT devices: experience counts

“Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?” A single centre experience

Current aspects of cardiac resynchronisation therapy

Echocardiography and cardiac resynchronisation therapy, friends or foes?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page